Trial Profile

An Open-label, Crossover Study of the Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol

Status: Discontinued

Phase of Trial: Phase I

Latest Information Update: 24 May 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs HM 30181A (Primary) ; Paclitaxel (Primary)
Indications Solid tumours
Focus Pharmacokinetics
Sponsors Athenex

Most Recent Events

19 May 2023 Status changed from recruiting to discontinued.
31 Oct 2022 Planned End Date changed from 31 Oct 2022 to 31 Oct 2023.
31 Oct 2022 Planned primary completion date changed from 15 Jul 2022 to 15 Jul 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com